Lv1
80 积分 2022-08-25 加入
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease
17天前
已完结
Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
18天前
已完结
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
18天前
已完结
Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis
19天前
已完结
Discovery and mechanism of ustekinumab: a human monoclonal antibody targeting interleukin-12 and interleukin-23 for treatment of immune-mediated disorders
26天前
已完结
Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12
26天前
已完结
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps
3个月前
已完结
Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma
3个月前
已完结
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
3个月前
已完结
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
3个月前
已完结
皖公网安备34019202002308
